№ lp_2_3_54555
This advisory outlines the new prescription labeling regulations for reproductive and gender-affirming medications in Massachusetts, following the signing of Chapter 16 of the Acts of 2025, which enhances privacy and protections for healthcare providers offering such care.
Year: 2025
Region / city: Massachusetts, Boston
Topic: Health care, reproductive and gender-affirming medications
Document type: Advisory
Organization / institution: Massachusetts Department of Public Health
Author: Massachusetts Department of Public Health
Target audience: Pharmacies, practitioners prescribing reproductive and gender-affirming medications
Effective period: Starting from August 7, 2025
Date of approval: December 18, 2025
Statutory authority: M.G.L. c. 94C §§ 21 and 22
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.